What are the specific causal mechanisms underlying the bidirectional relationship between depression and AD dementia?

OPEN

The abstract explicitly states that despite extensive research, the precise causal mechanisms and nature of the relationship between depression and AD remain incompletely understood. This fundamental gap prevents development of targeted interventions that could address both conditions simultaneously. Gap type: open_question Source paper: Neurobiological and therapeutic landmarks of depression associated with Alzheimer's disease dementia. (2025, Frontiers in aging neuroscience, PMID:40529210)

Priority: 0.85 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What are the specific causal mechanisms underlying the bidirectional relationship between depression and AD dementia? is a 0.85 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the specific causal mechanisms underlying the bidirectional relationship between depression and AD dementia? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (21)

entities-rosADentities-histone-methylationADentities-atp7b-geneADTAUADTDP-43AD
▸ Show 16 more

biomarker for (1)

tau cleavage productsAD

causes (6)

ADneurodegenerationPHOSPHORYLATED_TAUADBETA_AMYLOIDADADIMMUNE_TOLADmemory_loss
▸ Show 1 more

contributes to (1)

NEUROINFLAMMATIONAD

cross disease mechanism in (5)

MAPTADTREM2ADNLRP3ADPINK1ADGRNAD

depleted in (1)

SPM_levelsAD

prevents (1)

NAD+ augmentationAD

protective against (1)

cognitive stimulationAD

regulates (1)

ADPROTEOME

risk factor for (4)

genetically at-risk individualsADAPOE ε4ADmicroglial primingADAPOE4AD

targets (1)

resveratrolAD

therapeutic target for (6)

TREM2ADCCR2ADSaracatinibADanti-amyloid antibodiesADNAD+ augmentationAD
▸ Show 1 more

treats (1)

HTL9936AD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps